Stay updated on Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed from the page. This update does not change study details, eligibility criteria, or other user-facing content.
    Difference
    0.1%
    Check dated 2026-03-18T21:54:15.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3. The previous revision label v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-11T17:15:08.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; notices about government funding and Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T10:01:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page adds a government funding notice, a 'Results Submitted' indicator, and updates the revision to v3.4.1, replacing the previous 'No Results Posted' status and v3.4.0.
    Difference
    0.5%
    Check dated 2026-02-04T06:52:42.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Explicit site locations now show three UK sites: The Royal Marsden Hospitals at Sutton and London, Sutton (Surrey), and Guy's Cancer Centre in London. The study status has been updated to Completed.
    Difference
    2%
    Check dated 2026-01-28T04:48:41.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:57:10.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Cancer of Unknown Primary Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Cancer of Unknown Primary Clinical Trial page.